Form 8.3 The British Land Company Plc

Jefferies International Limited
09 April 2026
 

 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1.         KEY INFORMATION

 

(a) Full name of discloser:

Jefferies International Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

     The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.

 

 

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

     Use a separate form for each offeror/offeree

The British Land Company Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

 

(e) Date position held/dealing undertaken:

     For an opening position disclosure, state the latest practicable date prior to the disclosure

8th April 2026

(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

     If it is a cash offer or possible cash offer, state "N/A"

Life Science REIT Plc

 

 

2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in\ 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

 

Class of relevant security:

 

25p ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

 

 

43,057

0.004

(2) Cash-settled derivatives:

 

42,494

0.004

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

TOTAL:

42,494

0.004

43,057

0.004

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b)        Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a)        Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit (GBX)

25p ordinary

Purchase

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sale

32,072

 1,802

 3

 283

 2

 534

 9,148

 40,850

 33,387

 526

 332

 688

 34

 1,490

 458

 645

 946

 280

 7,061

 1,138

 441

 973

 1,076

 

32,301

 4

 4

 7,938

 7

 4

 14

 8

 4

 4

 2

 4

 8

 1

 20

 5

 1

 10

 1

 4

 2

 8

 4

 8

 4

 4

 4

 51,409

 4

 34

 4

 50,000

 4

 4

 4

 4

 5

 16

 8

 4

 4

 4

 12

 4

 4

 4

 8

 4

 4

 4

 8

 4

 12

 10

 20

 4

 3

 4

 12

 4

 8

 4

 4

 4

 8

 8

 4

 4

 10

 8

 6

 7

 8

 8

 4

 1

381.2000

382.7000

382.9000

383.2000

383.5000

383.6000

383.7000

383.8000

383.8500

384.1000

384.2000

384.2800

384.2979

384.3000

384.4000

384.8500

384.9500

385.1000

385.2500

385.3000

385.6000

385.7000

385.8000

 

381.2000

382.2000

382.5000

382.5500

382.6000

382.7000

382.8000

382.8500

382.9000

382.9500

383.0000

383.0500

383.1500

383.2000

383.3000

383.4000

383.4500

383.5000

383.6000

383.6500

383.7000

383.7500

383.8500

383.9500

384.0000

384.0500

384.1500

384.2390

384.2500

384.2979

384.3500

384.4000

384.5000

384.6500

384.7000

384.9000

385.0000

385.1000

385.1500

385.2500

385.3000

385.3500

385.4000

385.5500

385.8000

385.8500

386.2000

386.2500

386.3000

386.4000

386.5000

386.7000

387.0000

387.2000

387.4000

387.5500

387.6000

388.0000

388.1000

388.1500

388.4000

388.5000

388.6000

388.8000

389.0000

389.1000

389.2000

389.2500

389.3000

389.3500

389.5000

389.6000

389.7500

389.8000

390.0500

394.3000

 

(b)        Cash-settled derivative transactions

 

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(GBX)

25p ordinary





 

 

(c)        Stock-settled derivative transactions (including options)

 

(i)         Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit









 

(ii)        Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d)        Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

4.         OTHER INFORMATION

 

(a)        Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"

None

 

(b)        Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Non

 

(c)        Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

9th April 2026

Contact name:

Jason Williams

Telephone number

020 7029 8706

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings